What is it?
Utilizing cutting-edge science and Dr. Zein Obagi's extensive clinical experience creating treatments and regimens for healthy skin, ZO Skin Health, Inc. provides comprehensive skincare programs for their patients. As a result, ZO Skin Health, Inc. is focused on providing products and protocols that bridge the gap between therapeutic treatments and daily care that allow patients to experience continuously healthy skin regardless of their age or unique skin condition.
– NORMALIZE SKIN WITH PROPER CLEANSING
– REMOVE SURFACE DEBRIS
– PROMOTE EXFOLIATION TO IMPROVE CIRCULATION
– ENHANCE PRODUCT PENETRATION
– REMOVE DEAD SKIN CELLS
– CONTROL OIL
– RESTORE PH
– SOOTHE DRY SKIN
– REDUCE THE APPEARANCE OF FINE LINES
– PROMOTE A MORE EVEN SKIN TONE
– HELP PREVENT FUTURE SKIN DAMAGE
– LESSEN THE APPEARANCE OF DISCOLORATION
– PROMOTE A SMOOTH, EVEN SKIN TONE
– CONTROL EXCESS OIL PRODUCTION
– REMOVE DEAD SKIN CELLS
– STIMULATE HEALTHY CELL RENEWAL
– MINIMIZE INFLAMMATION
– DIMINISH SKIN REDNESS
– PROTECT AGAINST HARMFUL UVA/UVB RAYS,
HEV LIGHT AND POLLUTION
– PREVENT FUTURE SIGNS OF PREMATURE AGING
– REDUCE DARK CIRCLES UNDER THE EYES
– MINIMIZE FINE LINES AND WRINKLES
Important Safety Information for Obagi Nu-Derm Clear and Blender® (contains 4% hydroquinone)
People with prior history of sensitivity or allergic reaction to this product or any of its ingredients should not use it. The safety of topical hydroquinone use during pregnancy or in children (12 years and under) has not been established.
Avoid contact with eyes, nose, mouth, or lips. In case of accidental contact, patient should rinse eyes, nose, mouth, or lips with water and contact physician.
Sunscreen use is an essential aspect of hydroquinone therapy because even minimal sunlight exposure sustains melanocytic activity.
Contains sodium metabisulfite, a sulfite that may cause allergic-type reactions including anaphylactic symptoms and life-threatening or less severe asthmatic episodes in certain susceptible people. The overall prevalence of sulfite sensitivity in the general population is unknown and probably low. Sulfite sensitivity is seen more frequently in asthmatic than in nonasthmatic people.
PRECAUTIONS (ALSO SEE WARNINGS):
Treatment should be limited to relatively small areas of the body at one time since some patients experience a transient skin reddening and a mild burning sensation, which does not preclude treatment.
Pregnancy Category C: Animal reproduction studies have not been conducted with topical hydroquinone. It is also not known whether hydroquinone can cause fetal harm when used topically on a pregnant woman or affect reproductive capacity. It is not known to what degree, if any, topical hydroquinone is absorbed systemically. Topical hydroquinone should be used on pregnant women only when clearly indicated.
Nursing Mothers: It is not known whether topical hydroquinone is absorbed or excreted in human milk. Caution is advised when topical hydroquinone is used by a nursing mother.
Pediatric Usage: Safety and effectiveness in children below the age of 12 years have not been established. Use of the product should be discontinued if hypersensitivity to any of the ingredients is noted.